We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$20.4M
Cap. Flow
+$27.7M
Cap. Flow %
11.1%
Top 10 Hldgs %
64.01%
Holding
39
New
7
Increased
16
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$11.5M
2
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$10.4M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.87M
4
VZ icon
Verizon
VZ
+$9.36M
5
TAP icon
Molson Coors Class B
TAP
+$8.95M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$15.7M
2
KMI icon
Kinder Morgan
KMI
+$9.24M
3
SRCL
Stericycle Inc
SRCL
+$4.95M
4
FDX icon
FedEx
FDX
+$4.81M
5
MFIC icon
MidCap Financial Investment
MFIC
+$4.26M

Sector Composition

Rank Sector Weight
1 Financials 26.81%
2 Communication Services 19.36%
3 Healthcare 14.25%
4 Real Estate 11.28%
5 Consumer Staples 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
1
Verizon
VZ
$198B
$26M 10.39%
430,000
+162,500
+61% +$9.36M
RDN icon
2
Radian Group
RDN
$5.23B
$23.4M 9.38%
1,026,403
+171,403
+20% +$3.96M
CMCSA icon
3
Comcast
CMCSA
$81.9B
$22.4M 8.97%
497,500
+82,500
+20% +$3.66M
KKR icon
4
KKR & Co
KKR
$91.1B
$17.5M 6.99%
651,000
+238,500
+58% +$6.29M
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$16M 6.42%
290,000
+40,000
+16% +$2.14M
BMY icon
6
Bristol-Myers Squibb
BMY
$129B
$13.7M 5.48%
270,000
+210,000
+350% +$9.87M
TLT icon
7
iShares 20+ Year Treasury Bond ETF
TLT
$42.8B
$10.7M 4.29%
+75,000
New +$10.4M
DXC icon
8
DXC Technology
DXC
$1.71B
$10.5M 4.19%
355,000
+67,500
+23% +$2.88M
MO icon
9
Altria Group
MO
$122B
$10.2M 4.09%
+250,000
New +$11.5M
TAP icon
10
Molson Coors Class B
TAP
$7.75B
$9.49M 3.8%
+165,000
New +$8.95M
KREF
11
KKR Real Estate Finance Trust
KREF
$476M
$9.28M 3.71%
475,000
+127,237
+37% +$2.5M
STLA icon
12
Stellantis
STLA
$16.4B
$8.87M 3.55%
685,000
+49,571
+8% +$663K
VIRT icon
13
Virtu Financial
VIRT
$5.14B
$7.69M 3.08%
470,000
+60,000
+15% +$1.2M
FSK icon
14
FS KKR Capital
FSK
$3.04B
$7.49M 3%
321,250
-32,584
-9% -$764K
AGNC icon
15
AGNC Investment
AGNC
$12.4B
$6.84M 2.74%
425,000
-125,000
-23% -$2.05M
GM icon
16
General Motors
GM
$76.7B
$6.56M 2.62%
175,000
-70,000
-29% -$2.69M
AGN
17
DELISTED
Allergan plc
AGN
$5.89M 2.36%
35,000
-96,250
-73% -$15.7M
SRCL
18
DELISTED
Stericycle Inc
SRCL
$5.83M 2.33%
114,461
-106,411
-48% -$4.95M
TSLX icon
19
Sixth Street Specialty
TSLX
$1.64B
$4.87M 1.95%
232,100
+22,110
+11% +$449K
TWO
20
Two Harbors Investment
TWO
$1.27B
$4.27M 1.71%
81,250
+28,750
+55% +$1.52M
RITM icon
21
Rithm Capital
RITM
$5.19B
$3.92M 1.57%
+250,000
New +$3.74M
AVT icon
22
Avnet
AVT
$7.05B
$3.61M 1.45%
81,170
-43,830
-35% -$1.89M
BCIC
23
BCP Investment Corp
BCIC
$87.6M
$3.39M 1.36%
150,565
-2,743
-2% -$63.9K
OPI
24
DELISTED
Office Properties Income Trust
OPI
$2.15M 0.86%
70,000
+20,000
+40% +$559K
OHAI
25
DELISTED
OHA Investment Corporation
OHAI
$2.07M 0.83%
1,588,850
+50,945
+3% +$63K
1
2

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return

Callodine Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Callodine Capital Management held 39 positions worth $250M, up 8.9% from $230M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Callodine Capital Management deployed $27.7M of net new capital in Q3 2019, opening 7 new positions and adding to 16 existing holdings. Its largest new stake was Altria Group: 250,000 shares worth $10.2M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Allergan plc, an estimated $15.7M trimmed.

  • Callodine Capital Management's largest Q3 2019 buy was Altria Group: 250,000 shares worth $10.2M.
  • Callodine Capital Management added most to Bristol-Myers Squibb in Q3 2019, an estimated $9.87M increase.
  • Callodine Capital Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $15.7M.
  • Callodine Capital Management fully exited Kinder Morgan in Q3 2019, selling an estimated $9.24M.
  • Callodine Capital Management's ten largest holdings make up 64% of its $250M portfolio in Q3 2019.
  • Callodine Capital Management opened 7 new positions and closed 7 in Q3 2019.
  • Callodine Capital Management's portfolio value rose 8.9% quarter-over-quarter to $250M.

Based on Callodine Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.